Articles published by Ansa Biotechnologies, Inc.

Ansa Biotechnologies to Showcase Breakthrough DNA Synthesis Technology Backed by Industry’s Only On-Time Guarantee at SynBioBeta 2026 Conference

Today 8:03 EDT

From Ansa Biotechnologies, Inc.

Via Business Wire

Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service

October 01, 2025

From Ansa Biotechnologies, Inc.

Via Business Wire

Ansa Biotechnologies Breaks Traditional Synthetic DNA Length Barriers and Redefines Future of Life Science Research

May 06, 2025

From Ansa Biotechnologies, Inc.

Via Business Wire

Ansa Biotechnologies Pushes Limits of Complex DNA Synthesis with Launch of New Commercial Products

July 30, 2024

From Ansa Biotechnologies, Inc.

Via Business Wire

Ansa Biotechnologies Expands Successful Early Access Program for Complex DNA Synthesis

May 06, 2024

From Ansa Biotechnologies, Inc.

Via Business Wire

Ansa Biotechnologies to Showcase Early Access Customer Success at Upcoming Global Synthetic Biology Conference

April 30, 2024

From Ansa Biotechnologies, Inc.

Via Business Wire

Ansa Biotechnologies Announces First Shipments of Complex Clonal DNA Sequences to Customers in its Early Access Program

May 22, 2023

From Ansa Biotechnologies, Inc.

Via Business Wire

Ansa Biotechnologies Announces Successful de novo Synthesis of World’s Longest Oligonucleotide at 1005 Bases

March 09, 2023

From Ansa Biotechnologies, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.